| Michael O Royster, MD, MPH | |
|
301 Halifax St, Petersburg, VA 23803-6335 | |
| (804) 863-1652 | |
| (804) 862-6126 |
| Full Name | Michael O Royster |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 301 Halifax St, Petersburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861452450 | NPI | - | NPPES |
| 4975073 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 0101233567 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael O Royster, MD, MPH 301 Halifax St, Petersburg, VA 23803-6335 Ph: (804) 863-1652 | Michael O Royster, MD, MPH 301 Halifax St, Petersburg, VA 23803-6335 Ph: (804) 863-1652 |
News Archive
Researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) have published the first study on adherence to eight World Cancer Research Fund (WCRF) lifestyle recommendations and aggressive prostate cancer that shows a significantly decreased risk of highly aggressive prostate cancer associated with closer adherence to the recommendations.
Evidence from the teeth of Anglo Saxon children could help identify modern children most at risk from conditions such as obesity, diabetes and heart disease.
Kite, a Gilead Company, and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors, have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.
An examination of state vaccination requirements for adolescents finds that the human papillomavirus (HPV) vaccine is currently required in only two states, many fewer than another vaccine associated with sexual transmission (hepatitis B) and another primarily recommended for adolescents (meningococcal conjugate), according to a study in the July 14 issue of JAMA.
New research by scientists at Switzerland's Institute for Environmental Decisions reports that risk perception and public acceptance of NPIs depends on both worldview and levels of social trust. The study also found that, paradoxically, when the number of cases decreased in the period between the first and second waves, public willingness to comply with these measures fell.
› Verified 3 days ago
Dr. Charles Konigsberg Jr., MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Halifax St, Petersburg, VA 23803 Phone: 804-863-1652 Fax: 804-862-6126 |